ZNTL

Conviction 96HealthcareScan · Fri, Jun 26, 2026

Bullish engulfing

ZNTL$4.04+6.60%

ResistanceSupportVol 14

Vol MA14 951.01K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Zentalis Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.zentalis.com ↗

Price4.04

Change+6.60%

Gap-0.79%

Rel volume2.62×

Avg volume954.71K

Avg $ vol3.62M

SMA 203.75

SMA 503.95

SMA 2002.56

Price vs 50+2.23%

Price vs 200+58.09%

MA stackbullish

50/200 cross—

Supertrenddown · 4.43

RSI (14)57

MACD hist0.04

MACD crossbull · 2d

Stoch %K / %D95 / 80

ADX (14)13

+DI / −DI19 / 16

RSI divergence—

MACD divergence—

ATR %+7.17%

ADR %7.22%

52w high6.61

52w low1.16

From 52w high-38.88%

Above 52w low+248.28%

New 52w highNo

SqueezeOn · 31d

Bollinger width17.38%

%B0.95

Donchian pos90.51%

Donchian high4.11

Donchian low3.42

AVWAP (52w high)5.02

vs AVWAP high-19.47%

AVWAP (52w low)3.25

vs AVWAP low+24.49%

OBV trendFlat

Chaikin MF (20)0.06

Today vs 20d2.62×

Avg vol (14d)951.01K

Avg vol (20d)954.71K

Avg $ vol (20d)3.62M

Market cap—

RS 3m (vs SPY)+36.83%

RS 6m (vs SPY)+163.49%

RS line new highNo

Trend template7/8

Technical rank83.5

1 week+9.19%

1 month+0.50%

3 months+51.31%

6 months+199.26%

1 year+208.40%

YTD+194.89%

P/E-1.97

P/B1.48

P/S—

P/FCF-2.15

EPS-1.91

Div yield—

ROE-75.03%

ROA-54.16%

Debt/Eq—

Current6.19

EV/EBITDA-1.56

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth17.35%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value237.87M

Revenue0

Net income-35.35M

Gross profit—

Free cash flow-125.25M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out71.19M

Employees106

ListedFri, Apr 3, 2020

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction96 / 100

Pattern quality—

Tech rank83.5 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ZNTL

All disclosures →

No recent disclosed trades by Congress in ZNTL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ZNTL · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Johnson David Michael Director · Common Stock · 2026-06-16	Grant	57.1K	—	2026-06-16	2026-06-18
Myers Scott Dunseth Director · Common Stock · 2026-06-16	Grant	57.1K	—	2026-06-16	2026-06-18
Skvarka Jan Director · Common Stock · 2026-06-16	Grant	57.1K	—	2026-06-16	2026-06-18
Walker Luke Nathaniel Director · Common Stock · 2026-06-16	Grant	57.1K	—	2026-06-16	2026-06-18
Kariuki Enoch Director · Common Stock · 2026-06-16	Grant	57.1K	—	2026-06-16	2026-06-18
Campbell Shannon Director · Common Stock · 2026-05-26	Grant	114.2K	$0	2026-05-26	2026-05-27

SEC filings

EDGAR filings in ZNTL · 1 recent

EDGAR →

8-K8-KThu, Jun 18, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.